Ann: Regulatory Approval to Commence Sales for Striate in Canada, page-19

Hi Rae915,

$1 a lofty estimate given upcoming catalysts and revenue projection. I’ll be cool with $0.6-$0.7 Dec’24 but when Remplir gets US approval Q1/2 2025 I anticipate we should really see a climb towards $1.2-$1.5 range and then ideally $2-3 once we demonstrated a few quarters of profitability in early 2026.

My 2 cents and thesis, don’t mind a friendly gamble.

Was waiting on income later this month to load up on 35.5c and possibly double my relatively small 150K shares position. Train may have left the station unfortunately.

VFM